| Primary information |
|---|
| sequence ID | Seq_8182 |
| Peptide sequence | TGIFTDQVLSVLKGEE |
| CancerPDF_ID | CancerPDF_ID389, CancerPDF_ID7383, |
| PMID | 19795908,24982608 |
| Protein Name | Apolipoprotein C-II,Apolipoprotein C-II |
| UniprotKB Entry Name | APOC2_HUMAN,APOC2_HUMAN |
| Fluid | Plasma,Urine |
| M/Z | 868.46,NA |
| Charge | 2,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,Nano-LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,0.01 |
| CancerPDF_ID | CancerPDF_ID389, CancerPDF_ID7383, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,"GPM search engine, MASCOT" |
| Length | 16,16 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ovarian cancer |
| Database | NCBI refseq Protein Database,IPI 3.71 Human Database |
| Modification | NA,NA |
| Number of Patients | "41 normal, 24 patients",6 Ovarian cancer patients and 6 normal individuals |
| Regulation | NA,Uniquely present in case of urine of ovarian cancer patients |
| Validation | NA,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |